VC
Switzerland
New Fund 2024

HBM Healthcare Investments

Investment Focus

Geographic Focus

Global

Investment Thesis

Publicly listed Swiss investment company providing diversified exposure to the global healthcare sector through private venture capital and public equity positions.

How to Pitch HBM Healthcare Investments

No Stated Policy
HBM Healthcare Investments hasn't published an outreach policy. A short, specific cold email is the safest default.
Source

Portfolio Highlights

Vicore Pharma - respiratory disease biotech (active investment, Nov 2025)
SAI Life Sciences - CRO/CDMO (IPO on NSE/BSE, 2024 exit)
Yellow Jersey Therapeutics - acquired by Johnson & Johnson (2024 exit)

Focus and check size from the firm's website. Website reachable as of Aug 2026.

Ready to Reach HBM Healthcare Investments?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.